Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Evaxion A/S - Sponsored ADR (EVAX : NSDQ)

• Company Description    Evaxion A/S is a clinical-stage TechBio company specializing in developing AI-Immunology(TM) powered vaccines. Evaxion A/S, formerly known as Evaxion Biotech A/S, is based in COPENHAGEN, Denmark. Number of Employees: 46

• Price / Volume Information    Yesterday's Closing Price: $3.78 Daily Weekly Monthly 20 Day Moving Average: 34,862 shares Shares Outstanding: 8.34 (millions) Market Capitalization: $31.53 (millions) Beta: 0.28 52 Week High: $12.15 52 Week Low: $1.20 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 13.85% 18.27% 12 Week -23.17% -19.61% Year To Date -20.75% -18.11%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL Dr. Neergaards Vej 5F - Hoersholm,G7 2970 DNK ph: 45-3131-9753 fax: - mak@evaxion.ai http://www.evaxion.ai

• General Corporate Information    Officers Helen Tayton-Martin - Chief Executive Officer Marianne Sogaard - Chairman of the Board of Directors Thomas Frederik Schmidt - Chief Financial Officer Lars Holtug - Director Roberto Prego - Director Peer Information Evaxion A/S - Sponsored ADR (HLIS) Evaxion A/S - Sponsored ADR (AZTA) Evaxion A/S - Sponsored ADR (APYI) Evaxion A/S - Sponsored ADR (RNVA) Evaxion A/S - Sponsored ADR (HMSY) Evaxion A/S - Sponsored ADR (LRSI) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MEDICAL INFO SYS Sector: Medical CUSIP: 29970R303 SIC: 2836 Fiscal Year Fiscal Year End: December Last Reported Quarter: 12/01/25 Next Expected EPS Date: 05/26/26 Share - Related Items Shares Outstanding: 8.34 Most Recent Split Date: 1.00 (0.20:1) Beta: 0.28 Market Capitalization: $31.53 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.50 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 05/26/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 1.85 Price/Cash Flow: - Price / Sales: 9.43 EPS Growth vs. Year Ago Period: -1,328.57% vs. Previous Quarter: -236.99% Sales Growth vs. Year Ago Period: 148.33% vs. Previous Quarter: 20,148.65% ROE 12/31/25 - -61.43 09/30/25 - -68.82 06/30/25 - -321.11 ROA 12/31/25 - -29.14 09/30/25 - -24.12 06/30/25 - -79.60 Current Ratio 12/31/25 - 5.85 09/30/25 - - 06/30/25 - 3.42 Quick Ratio 12/31/25 - 5.85 09/30/25 - - 06/30/25 - 3.42 Operating Margin 12/31/25 - - 09/30/25 - - 06/30/25 - - Net Margin 12/31/25 - - 09/30/25 - - 06/30/25 - - Pre-Tax Margin 12/31/25 - -114.44 09/30/25 - -82.98 06/30/25 - -400.88 Book Value 12/31/25 - 2.04 09/30/25 - 2.63 06/30/25 - 0.99 Inventory Turnover 12/31/25 - - 09/30/25 - - 06/30/25 - - Debt-to-Equity 12/31/25 - 0.41 09/30/25 - 0.00 06/30/25 - 1.73 Debt-to-Capital 12/31/25 - 28.98 09/30/25 - 0.00 06/30/25 - 63.31

Powered by Zacks Investment Research ©